Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation

Clinical trial NCT04368442 · UNKNOWN

Trial details

NCT number: NCT04368442
Sponsor: Samsung Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Breast Cancer Metastatic

Start date: 2019-10-17
Primary completion: 2020-12-31
Enrollment: 583

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.